LGR5 and cancer: Moreover, EGF suppresses the expression of LGR5 (a co-receptor for Wnt/β-catenin signaling and marker of both normal intestinal stem cells and cancer stem cells) finely regulated during the adenoma-carcinoma progression, the development and maintenance of CRC-derived metastasis [58, 59].